EVALUASI ADRs (ADVERSE DRUG REACTIONS) PADA PASIEN ASMA RAWAT INAP DI RUMAH SAKIT X KUDUS
DOI:
https://doi.org/10.51225/jps.v9i1.98Keywords:
Asma, ADR (Adverse Drug Reactios), Jenis TerapiAbstract
Asthma is a chronic inflammatory disorder of the respiratory tract. Adverse drug reactions (ADRs) are responses to adverse and unwanted drugs that occur at doses normally used in humans for the prevention, diagnosis, or therapy of disease or for physiological function modification. The purpose of this study was to determine the type of therapy that was often used and to determine the number of ADRs in asthma patients hospitalized at X Hospital in 2021. This study was an observational study using a non-experimental descriptive method with retrospective data collection. The data was taken from medical record searches and side effects monitoring sheet. The patients in the inclusion criteria were 42 patients; their data were processed statistically using univariate analysis with a frequency test. The results showed that the types of therapy that were often used in the treatment of asthma were topical therapy 51 (35.7%), parenteral therapy 49 (34.3%), while oral therapy was 43 (30.1%). As well as the number of ADRs (Advers Drug Reactions) with complaints of chest palpitations and tremors on salbutamol treatment as many as 4 patients (23.5%), nausea, vomiting on aminophylline treatment as many as 4 patients (23.5%), digestive disorders on methylprednisolone as many as 2 patients (11.8%), and the incidence of dry or painful mouth and throat, hoarseness on ventolin nebulizer treatment was 7 patients (41.2%).
References
A.R. Yuliana, S. I. A. (2017). Terapi Nebulizer Mengurangi Sesak Nafas Pada Serangan Asma Bronkiale di Ruang IGD RSUD dr. Loekmono Hadi Kudus.
Alotia, G. S., Wiyono, W. I., & Mpila, D. A. (2020). Evaluasi Penggunaan Obat Pada Pasien Asma Di Instalasi Rawat Inap Rsup Prof. Dr. R. D. Kandou Manado. Pharmacon: 9(4), 613.
Anwar, A. N. Y., Agustina, R., dan Fadraersada, J. (2017). Kajian Terapi Asma dan Tingkat Kontrol Asma berdasarkan Asthma Control Test (ACT). Mulawarman Pharmaceutical Conference, November; 7–8.
Arief Bakhtiar, W. S. A., dan Departemen. (2016). Faal Paru Statis. Jurnal Respirasi: 2(3), 91–98.
Chinnusamy, K., Manoj, M., Thilaegsh, P., 2023, An Observational Study on the Short Term ADRs of Salbutamol Inhalation in Pulmonary Infections. International Journal of Pharmaceutical and Research and Application: 8(6), 2211-2222.
GINA. (2014). Global strategy for Asthma Management and Prevention. Global Initiative for Asthma: 4, 56–61.
GINA. (2015). Global Strategy For Asthma Management And Prevention. Global Initiative for Asthma.
Kementerian Kesehatan RI. (2013). Riset Kesehatan Dasar Riskesdas (2013). Badan Penelitian Dan Pengembangan Kesehatan Kementerian Kesehatan R, 85.
Litanto, A., dan Kartini, K. (2020). Kekambuhan asma pada perempuan dan berbagai faktor yang memengaruhinya. Jurnal Biomedika Dan Kesehatan: 4(2), 79–86.
Lorensia, A., dan Amelia, R. A. (2015). Studi Farmakovigilans Pengobatan Asma Pada Pasien Rawat Inap disuatu Rumah Sakit di Bojonegoro. Jurnal Ilmiah Manuntung: 1(1), 1–99.
Lutfiyati, H., Ikawati, Z., dan Wiedyaningsih, C. (2015). Efek Samping Penggunaan Terapi Oral Pada Pasien Asma. Jurnal Farmasi Sains Dan Praktis: 1(1), 21–28.
Martín Conde, M. T. (2014). Drug-related problems. Medicina Clinica: 124(7), 261–262.
Nuryati. (2017). Bahan Ajar Rekam Medis Dan Informasi Kesehatan (PMIK). Farmakologi.
PDPI. (2019). Pedoman Diagnosis dan Penatalaksanaan ASMA di Indonesia. In Pedoman diagnosis dan penatalaksanaan asma di Indonesia.
Rahmawati, N., D., Hilmi I., L., Salman. 2023). Review of the Analysis of the Effectiveness and Risk of Aminophylline Toxicity in the Treatment of Astma. Journal of Pharmaceutical and Sciences: 6(1), 95-99
Ratna Mafruhah, O., Syaputra, B., dan Pradiftha S; C. (2016). Evaluasi Efektivitas Terapi Pada Pasien Asma Di Rumah Sakit Khusus Paru Respira Yogyakarta Daerah Upkpm Kalasan Periode November 2014 - Januari 2015. Jurnal Ilmiah Farmasi: 12(2), 36–44.
Riskesdas. (2018). Laporan Riskesdas Nasional 2018: 120.
Rozaliyani, A., Susanto, A. D., Swidarmoko, B., Yunus, F., (2011). Mekanisme Resistens Kortikosteroid Pada Asma. J Respir Indo: 31(4).
S Hiremath, P., A Bhonsle, S., Thumma, S., dan Vemulapalli, V. (2011). Recent patents on oral combination drug delivery and formulations. Recent Patents on Drug Delivery & Formulation: 5(1), 52–60.
Sondakh, S. A., Onibala, F., dan Nurmansyah, M. (2020). Pengaruh Pemberian Nebulisasi Terhadap Frekuensi. Jurnal Keperawatan: 8, 75–82.
Yanhendri, & Yenny, S. W. (2012). Berbagai Bentuk Sediaan Topikal dalam Dermatologi dalam Dermatologi. Cdk-194: 39, 423–430.
Yosmar, R., Andani, M., & Arifin, H. (2015). Kajian Regimen Dosis Penggunaan Obat Asma pada Pasien Pediatri Rawat Inap di Bangsal Anak RSUP. Dr. M. Djamil Padang. Jurnal Sains Farmasi & Klinis: 2(1), 22–29.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Heni Setyoningsih, Shelli Apriliyani, Hasty Martha Wijaya
This work is licensed under a Creative Commons Attribution 4.0 International License.
